Predict your next investment

HEALTHCARE | Biotechnology
algaehealthsciences.com

See what CB Insights has to offer

Stage

Merger | Merged

About Algae Health Sciences

Algae Health Sciences has been researching, producing and marketing health-giving ingredients produced from algae.

Algae Health Sciences Headquarter Location

18301 Von Karman Avenue Suite 910

Irvine, California, 92612,

United States

949-748-7436

Latest Algae Health Sciences News

Two Recent Human Clinical Trials Establish Algae Health Sciences AstaZine as the Astaxanthin Category Leader for Brain Health

Nov 15, 2019

Algae Health Sciences, a division of BGG, announced the peer-reviewed publication of two double-blind, placebo-controlled human clinical trials using AstaZine® on brain health. In the first study (done in USA), significant improvements in three critical markers including feelings of depression , mental fatigue and overall mood state [psychological well-being] were found after 8 weeks in healthy subjects aged 26 to 63 years (median age = 42) taking AstaZine® (Talbott, 2019). In addition, trends toward improvement in other important mental health parameters such as tension, anger and mental confusion were found through AstaZine® supplementation. The second study (done in Japan) looked at very different yet crucial aspects of brain health. The subjects in this study were healthy adults who were experiencing mild forgetfulness. After twelve weeks taking AstaZine®, the treatment group showed a statistically significant improvement versus placebo on two tests for cognitive function and memory. Both verbal and composite memory significantly improved as tested by Cognitrax (a computerized testing system used to monitor and measure brain performance). In addition, subjective assessment of symptoms such as remembering people’s names and the names of things were judged by the AstaZine® group as having significantly improved (Sekikawa, 2019). These two studies are particularly significant because they establish AstaZine® as the leading Astaxanthin product for brain health, a quickly growing category in the supplement industry. “We’re extremely pleased to have two additional successful clinical trials for AstaZine® under our belt,” remarked Yanmei Li, PhD, Chief Scientific Officer of BGG. “Our goal is to maintain a leadership role in the botanical sector through innovation and continuing scientific discoveries.” References: Talbott, S., Hantla, D., Capelli, B., Ding, L., Li, Y., Artaria, C. “Astaxanthin Supplementation Reduces Depression and Fatigue in Healthy Subjects.” EC Nutrition 14.3 (2019): 239-246. Sekikawa, T., Kizawa, Y., Li, Y., Takara., T. “Cognitive Function Improvement with Astaxanthin Intake: A Randomized, Double-Blind, Placebo-Controlled Study.” Pharmacometrics 97 (1/2) 1-13 (2019). ********** About Algae Health Sciences, Inc: Algae Health Sciences, Inc., a subsidiary of BGG, focuses on the production and marketing of efficacious ingredients from natural algae sources. With the second largest capacity to produce Natural Astaxanthin from microalgae, Algae Health Sciences plans to become the world’s largest producer by 2022. The company has facilities in USA, Switzerland, Japan and China. Further Information on Algae Health Sciences: http://www.algaehealthsciences.com ********** About BGG: BGG is a global B2B supplier of ingredients sourced from nature that improve consumer wellness. Building on 25 years of innovative leadership, BGG provides consumer product makers with efficacious ingredients of outstanding quality. This is achieved by specialized sourcing, cultivation and production in the best global regions. BGG’s extensive portfolio originates from algae, fruits and plants. BGG employs a staff of approximately 400, has 6 production sites, international branches in North America, Japan, China and Switzerland and manages sales in over 100 countries. BGG is ISO9001, ISO22000 and GMP certified. Further Information on BGG: http://www.bggworld.com **********

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.